Use of lung function tests in asthmatic children is associated with lower risk of hospitalization. A Danish

Grete Moth1, Peter Oluf Schiotz, Erik Parner

  • 1Danish Paediatric Asthma Centre, Aarhus University Hospital, Aarhus, Denmark. grete.moth@alm.au.dk

Insights

Adhering to asthma guidelines, including lung function tests and a controller-to-total medication ratio of 0.5, significantly reduces hospitalization risk in children. This supports better asthma management and improved patient outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Public Health

Background:

  • Childhood asthma is a prevalent chronic condition with significant variations in hospitalization rates.
  • Current asthma management guidelines are frequently debated regarding adherence and appropriateness.
  • Understanding factors influencing asthma-related hospitalizations is crucial for effective pediatric care.

Purpose of the Study:

  • To investigate the association between adherence to asthma guidelines and the risk of hospitalization in children.
  • Specifically, to examine the impact of lung function tests at diagnosis and during follow-up on hospitalization risk.
  • To assess the role of medication adherence (controller-to-total medication ratio) in pediatric asthma hospitalizations.

Main Methods:

  • A nationwide, population-based cohort study in Denmark (1999-2004) utilized linked registry data.
  • Asthmatic children aged 6-14 were analyzed for lung function test utilization and medication ratios.
  • Cox regression models calculated adjusted hazard ratios for hospitalization risk.

Main Results:

  • A total of 27,193 children were followed for at least one year post-medication initiation.
  • Lung function tests at treatment start were associated with a 36% reduced hospitalization risk (HR 0.64).
  • A controller-to-total medication ratio ≥ 0.5 correlated with a 33% lower hospitalization risk (HR 0.67).

Conclusions:

  • Adherence to lung function testing guidelines in pediatric asthma is linked to decreased hospitalization rates.
  • An adequate controller-to-total medication ratio is also associated with a reduced risk of asthma-related hospitalizations.
  • These findings underscore the importance of guideline adherence for optimizing asthma management in children.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...